AzTrials
AzTrials

Posttraumatic Stress DisorderYOGAPTSDNCT03748121

Yoga/Pranayama for Posttraumatic Stress Disorder

A study testing Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT) and Trauma-focused Cognitive Behavioral Therapy (TF-CBT) in people with Posttraumatic Stress Disorder, run by Universität Duisburg-Essen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate the effect of a pranayama focused yoga intervention on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard psychotherapy/ trauma-focused cognitive-behavioral therapy (TF-CBT). Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Posttraumatic Stress Disorder
What is being tested?
Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT) and Trauma-focused Cognitive Behavioral Therapy (TF-CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteGermany
Study dates
20 Feb 2018to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed PTSD according to ICD-10
  • PCL-5 Score of at least 33 points
  • Undergoing outpatient CBT
  • Physical and mental ability to perform Pranayama

Who cannot join

  • Severe comorbid mental or somatic disease that did not allow the patient to perform Pranayama
  • Pregnancy
  • Regular practice of Yoga or Pilates in the last 12 months

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Dietmar Mitzinger

    Neuss, North Rhine-Westphalia, 41460

Other trials in Germany

About this study

Official title: Pranayama Assisted Psychotherapy in Patients With Post-traumatic Stress Disorder: a Randomized-controlled Trial

This study aims to investigate the effect of a pranayama focused yoga intervention on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard psychotherapy/ trauma-focused cognitive-behavioral therapy (TF-CBT). Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of standard TF-CBT unit, while the control group will get standard TF-CBT alone. It should further be investigated, whether pranayama can enhance the affective tolerance of patients with post-traumatic stress disorder towards the used exposure techniques of TF-CBT.

Being tested
Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT), Trauma-focused Cognitive Behavioral Therapy (TF-CBT)
Keywords
Posttraumatic Stress Disorder, Cognitive-Behavioral Therapy, Complementary Therapies, Yoga, Pranayama, Effectiveness, Safety, Randomized Controlled Trial
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT)Behavioural

    The pranayama intervention is placed directly at the begin of the respective TF-CBT unit and will be repeated for 10 subsequent TF-CBT units. Pranayama contains the performance of Kapalabhati, Ujjayi, and/or Nadi Shodhana (for overall 1 minute) as well as following Kumbhaka (intentional respiratory reflex inhibition). Pranayama will be repeated 3 times before each TF-CBT unit.

  • Trauma-focused Cognitive Behavioral Therapy (TF-CBT)Behavioural

    Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

Study groups in NCT03748121
Study groupRoleWhat they receive
Pranayama assisted Trauma-focused Cognitive Behavioral Therapy (TF-CBT)ExperimentalTo prepare patients for the TF-CBT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-CBT units.
Receives: Behavioral: Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT)
Trauma-focused Cognitive Behavioral Therapy (TF-CBT)Active comparatorPatients wait for 10 TF-CBT units and then are offered to learn pranayama.
Receives: Behavioral: Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intensity of posttraumtic symptoms

    Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

    Measured: week 10

Secondary outcomes (10)
  1. Health-related quality of life

    Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.

    Measured: week 10

  2. Ability of social participation

    Patient-Reported Outcomes Measurement Information System - Ability to Participate in Social Roles and Activities Scale (PROMIS): The PROMIS-Social Participation Subscale is a standard 8-item scale ranging from 0 to 100 points with 100 points represent the highest possible ability to participate/function.

    Measured: week 10

  3. Anxiety

    Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.

    Measured: week 10

  4. Depression

    Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.

    Measured: week 10

  5. Distress Tolerance

    Distress Tolerance Scale (DTS): The DTS is a standard 15-item scale ranging from 0 to 75 points. Higher scores represent higher distress tolerance.

    Measured: week 10

  6. Emotion Regulation

    Emotion Regulation Scale (ERQ): The ERQ is a standard 10-item scale with 6 items are added to the Cognitive Reappraisal subscale ranging from 6 to 42 and 4 items are added to the Expressive Suppression subscale ranging from 4 to 28. Higher scores on the Cognitive Reappraisal subscale and lower ones on the Expressive Suppression subscale represent a better regulation of emotions.

    Measured: week 10

  7. Body Awareness

    Scale of Body Connection (SBC): The SBC is a standard 20-items scale ranging from 0 to 80 that contains two subscales: Body Awareness and Body Dissociation. Higher scores on Body Awareness and lower scores on Body Dissociation represent a better body awareness.

    Measured: week 10

  8. Breath Holding Duration

    Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex. In PTSD patients, it is associated with distress tolerance.

    Measured: week 10

  9. Acute Emotional Stress

    Emotional Stress Reaction Questionnaire (ESRQ): The ESRQ is standard 14-items scale ranging from -21 points (predominance of negative emotions) to +21 points (predominance of positive emotions). Patients received the ESRQ before and after each CBT unit.

    Measured: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10

  10. Adverse Events

    Number of patients with adverse events (and type of the adverse event)

    Measured: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2018
  2. Study start20 Feb 2018
  3. Primary completion31 Jul 2020
  4. Study completion31 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03748121
Sponsor's protocol ID
17-7703-BO
Acronym
YOGAPTSD
Status last verified
Dec 2022
First submitted
16 Nov 2018
Last updated
6 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Upon reasonable request.

Publications

  • Haller H, Mitzinger D, Cramer H. The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized controlled trial. Front Psychiatry. 2023 Apr 17;14:1101046. doi: 10.3389/fpsyt.2023.1101046. eCollection 2023.

    PubMed 37139325

Questions about this trial

What is this clinical trial studying?

A study testing Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT) and Trauma-focused Cognitive Behavioral Therapy (TF-CBT) in people with Posttraumatic Stress Disorder, run by Universität Duisburg-Essen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intensity of posttraumtic symptoms (time frame: week 10). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03748121, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in